Insider Transactions in Q1 2022 at Eiger Bio Pharmaceuticals, Inc. (EIGR)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 14
2022
|
Eldon C. Mayer Iii Ex VP & Chief Commerc. Officer |
SELL
Open market or private sale
|
Direct |
1,657
-2.67%
|
$8,285
$5.6 P/Share
|
|
Mar 14
2022
|
Sriram Ryali Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,266
-5.17%
|
$11,330
$5.6 P/Share
|
|
Mar 11
2022
|
David Apelian CEO |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+27.27%
|
-
|
|
Mar 11
2022
|
Erik Atkisson GC & Chief Compliance Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+50.0%
|
-
|
|
Mar 11
2022
|
David A Cory President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
47,000
+21.74%
|
-
|
|
Mar 11
2022
|
Thomas John Dietz |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+12.12%
|
-
|
|
Mar 11
2022
|
Evan Loh |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+30.0%
|
-
|
|
Mar 11
2022
|
Jeffrey S Glenn |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+6.79%
|
-
|
|
Mar 11
2022
|
Eldon C. Mayer Iii Ex VP & Chief Commerc. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,000
+20.48%
|
-
|
|
Mar 11
2022
|
Christine Murray |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+27.27%
|
-
|
|
Mar 11
2022
|
Sriram Ryali Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,000
+35.38%
|
-
|
|
Mar 11
2022
|
Kim Sablich |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+50.0%
|
-
|
|
Mar 11
2022
|
Amit Sachdev |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+27.27%
|
-
|
|
Jan 07
2022
|
Eldon C. Mayer Iii Ex VP & Chief Commerc. Officer |
SELL
Open market or private sale
|
Direct |
1,560
-3.27%
|
$6,240
$4.95 P/Share
|